2020-08-04
Description
Webinar: The Interplay between the Gut Microbiome, Inflammation, Reproductive Hormones, and Mood Disorders
Location: Online Via PsychU.org
Description: Accumulating evidence suggests that changes in inflammation, including the gut microbiome, may contribute to the pathophysiology of mood disorders. Furthermore, inflammation may be involved in the sex differences we see in many diseases of the “modern” world. In this webinar, Mary Kimmel, MD and David J. Scheiderer, MD, MBA, DFAPA will review how changes in the gut microbiome can lead to changes in inflammation, the bi-directional relationship between inflammation and estrogen, as well as the bi-directional relationship between estrogen and the gut microbiome. There may be interplay among all these separate entities and this interplay may greatly impact the outcomes of the patients.
Speakers are paid consultants for Otsuka Pharmaceutical Development & Commercialization, Inc.
View Flyer (PDF)Event Speakers
Mary Kimmel, MD
Assistant Professor, Medical Director of NC Maternal Mental Health MATTERS Program, and Medical Director, UNC’s Perinatal Psychiatry Inpatient Unit (PPIU), and Associate Member of UNC’s Center for Gastrointestinal Biology and Disease
Assistant Professor, Medical Director of NC Maternal Mental Health MATTERS Program, and Medical Director, UNC’s Perinatal Psychiatry Inpatient Unit (PPIU), and Associate Member of UNC’s Center for Gastrointestinal Biology and Disease
Mary Kimmel, MD is an Assistant Professor, Medical Director of NC Maternal Mental Health MATTERS program, and Medical Director of the UNC’s Perinatal Psychiatry Inpatient Unit (PPIU), and associate member of UNC’s Center for Gastrointestinal Biology and Disease. The PPIU is the first psychiatric inpatient unit in the U.S. dedicated to the care of women during pregnancy and in the postpartum period. NC Maternal Mental Health MATTERS program is being developed to improve screening and treatment of maternal depression in North Carolina. Dr. Kimmel has received funding from the NIMH, the Brain & Behavior Research Foundation, and the Foundation of Hope. Dr. Kimmel’s research focuses on the microbiota-gut-brain axis and stress reactivity across the perinatal period (pregnancy through the postpartum period) in relation to the development of maternal mood and anxiety disorders and the child’s psychological development. Dr. Kimmel has published numerous articles on the microbiome and maternal-child mental health. The ultimate goal of her research is to develop novel diagnostic, prevention, and treatment tools utilizing the microbiota-gut-brain axis and to integrate them into clinical services.
David J. Scheiderer, MD, MBA, DFAPA
Chief Medical Officer and Director of Education at Integrative Psychiatry, Inc. & President of Tiberius Enterprises, Inc.
Chief Medical Officer and Director of Education at Integrative Psychiatry, Inc. & President of Tiberius Enterprises, Inc.
David J. Scheiderer, MD, MBA, DFAPA, is the Chief Medical Officer and Director of Education at Integrative Psychiatry, Inc. in Sarasota, Florida and the President of Tiberius Enterprises, Inc. in Roanoke, Virginia. An accomplished clinician, educator, and lecturer, Dr. Dave has established himself as a key opinion leader in the fields both of conventional mainstream psychiatry as well as functional medicine. As such, he is one of the most highly sought speakers in the nation on the topics of mental health and healthy aging. Dr. Dave also serves on numerous advisory boards and currently provides professional and technical expertise to several international corporations. In addition to his busy lecturing and consulting schedule, Dr. Dave maintains a private practice of integrative psychiatry in Sarasota.